BioCentury
ARTICLE | Financial News

Erasca launches to target cancer drivers

December 18, 2018 1:02 PM UTC

Oncology company Erasca Inc. (San Diego, Calif.) launched Tuesday with an untranched $42 million series A round and a basket of discovery programs targeting undisclosed cancer drivers.

The financing was co-led by founding investors City Hill Ventures and Cormorant Asset Management with participation from undisclosed institutional and individual investors...